Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class III drug recalls - low risk

Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.

1,716 recalls, newest first.

Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up American Health Packaging D-1235-2015
Class III · Low risk

Desmopressin Acetate Tablets

Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.

Terminated Labeling / mix-up Actavis Laboratories, FL, Inc. D-1285-2015
Class III · Low risk

Cortisol-Mc

Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.

Terminated Wrong potency / content Abrams Royal Pharmacy II, LLC NDC 88888-0043-31 D-1231-2015
Class III · Low risk

Disulfiram tablets

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.

Terminated Dissolution failure Qualitest Pharmaceuticals NDC 0603-3432-21 D1151-2015
Class III · Low risk

Carb-O-Philic 40 Cream

CGMP Deviation: Poor container closure of the bulk storage container

Terminated Packaging defect Geritrex Corp NDC 54162-640-03 D-1238-2015
Class III · Low risk

Dr Blue Pain Relieving Gel

Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.

Terminated Wrong potency / content Indiana Botanic Gardens, Inc NDC 10578-035-05 D-1149-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1138-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1137-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Terminated Impurity / degradation West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015

Recalls by year